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Summary
The remodelling process of bone acted by osteoblastic and
osteoclastic cells allows the tissue to maintain its integrity
and mechanical properties. Systemic factors, such as
hormonal status, nutrition, physical inactivity, exposure to
smoking, alcohol, or particular drugs, as well as  a local
variation in the load, can influence bone turnover, and
consequently, bone mass. In this paper, physical and
biochemical factors are described, which are crucially
important during the period of growth, i.e. childhood and
adolescence, for the construction of a healthy bone.
KEY WORDS: bone metabolism; peak bone mass; children; vitamin D; bone
growth.
Introduction
Bone is a “dynamic” and highly specialized connective tissue,
whose main function is to provide a mechanical support for
muscular activity and physical protection to the tissues and
internal organs, as well as to act as a repository for the
systemic mineral homeostasis (1).
It is a complex living tissue, where the extracellular matrix
produced by osteoblastic cells is mineralized, so as to give
rigidity and resistance to the skeleton, while maintaining a
certain degree of elasticity (1).
Morphologically, we can recognize two types of bone: the cortical
(compact) and the trabecular (spongy) component (Figure 1).
Cortical bone accounts for almost 80% of skeletal mass and it is
located in diaphyseal regions of long bones such as femur in the
lower limb or radio in the upper limb. Cortical bone is chara-
cterized by strip, by densely formed collagen fibrils, concentrically
arranged in cylindrical structures called Haversian systems,
which surround a central channel where we can find blood
vessels, lymphatics and nerves (Figure 1) (2).
Mini-review
Figure 1 - Main morphostru-
ctural features of bone.
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Trabecular bone, on the contrary, is located inside of the
cortical bone and predominates in the axial skeleton, such as
the rib cage and the spine; it also occupies the ends of long
bones, in which the cortical bone becomes thinner. Trabecular
bone consists of a porous network of thin wires called
trabeculae, whose position is determined by the pressure
exerted on bones during the development.
The differences in the structural arrangement of these two
types of bone are essentially linked to their primary functions:
cortical bone provides most of mechanical and protective
functions, while trabecular bone mainly provides metabolic
functions (3, 4).
The three main components of bone are represented by bone
cells, organic matrix, and minerals (the latter component
constitutes about two-thirds of dry weight of bone tissue). In
fact, skeleton represents the main body storage for many
minerals, which may be issued from it, via bone resorption, in
case of need. The mineral part is mainly composed by crystals
of calcium and phosphate in the form of hydroxyapatite, while
even small amounts of magnesium, carbonate, and sodium can
be found absorbed on the crystals (5-7).
The crystals minerals contribute also to provide mechanical
rigidity and strength for load-bearing bones. In fact, the size
and the distribution of mineral crystals in the bone matrix may
affect the mechanical properties of bone: for example, if
crystals are few or too small, the mechanical strength will be
altered; similarly, if there are too many crystals, the bones may
become brittle and therefore not able to bear a load (5, 7).
Bone tissue is constantly active both in adults and in children
and adolescents; “old” bone is in fact continuously replaced by
new bone. This remodelling process occurs in precise sites
defined unit of bone remodelling: after the resorption of a
mineralized surface by osteoclasts, osteoblasts are recruited
and secrete new bone matrix capable of gradually fill the cavity
of resorption (Figure 2) (4, 5).
Bone remodelling is greater than in the trabecular bone cortex.
In the stationary state, once the final height is reached, the
coupling between formation and bone resorption can maintain
bone mass.
Bone turnover can be influenced by both systemic and local
factors; among the first, the main factors are hormonal status,
nutrition, exposure to smoking, alcohol, or certain drugs and
physical inactivity; the most frequent local determinant is a
variation in the load. Thus, an imbalance of any of this factors
can lead to a variation in bone mass: for example, during life
phases characterized by loss of bone, such as menopause, the
resorption rate exceeds the formation one, while during the
period of growth, such as childhood and adolescence, there is
a build up of bone tissue (bone modelling), which is obtained
both from the appositional growth along the periosteal surface
and from the calcification of cartilage in the growth plate (1).
In the growing child, either the remodelling of mineralized bone
tissue and the formation of new bone are among the main
processes of bone remodelling, leading to neo-apposition (1).
Characteristics of bone tissue during growth
Childhood and adolescence are typically characterized by both
a longitudinal growth as well as changes in the size and shape
of the skeleton (3, 4).
During childhood, the height growth is relatively stable; up to 4
years the girls grow slightly faster than the boys; then, for both
sexes, growth has an average speed of 5-6 cm and 2,500 kg per
year until puberty. From early childhood to late adolescence, in
addition, the activity of bone formation predominates on bone
resorption, with a steady accumulation of skeletal mass, which
increases approximately by 70-95 g at birth to 2,400 to 3,300
grams in young women and men, respectively (1-6).
The completion of the normal skeletal growth requires adequate
production of thyroid hormones, growth hormone, growth factors
and sex steroids. Before the puberty, bone growth depends in
large part by growth hormone, but sex steroids are essential for
the completion of the maturation of the epiphysis and affixing
bone mineral during puberty and adolescence (6-8).
On all these processes influenced by this complex sequence
of hormonal changes, also nutritional and environmental factors
interact, able to modify the genetic potential of the individual.
Figure 2 - The cycle of bone re-
modelling. In normal conditions,
the phase of resorption (osteo-
clasts) lasts about 10 days, fol-
lowed by the step of formation
(osteoblasts), which can last
about 3 months.
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Together with the impact on growth as a whole, puberty has a
fundamental role in the acquisition of bone mass (Figure 3) (9).
In fact, between the beginning of puberty and adulthood,
skeletal mass doubles. However, this “accumulation” takes
place at different speeds depending on the skeletal segment
considered. In particular, the gain of the appendicular skeleton
is predominant before puberty, after which, under the influence
of sex steroids, there is an increase of the spine growth.
Moreover, the growth of the limbs is completed before the
growth of the axial skeleton (4, 5, 9).
It is interesting to note that, since the bone mass increase
during puberty follows the peak velocity of growth at least 6-12
months later, bone could be relatively undermineralized.
Fortunately, this period is normally only transient, since the
accumulation of bone mass continues after the completion of
longitudinal growth of an individual.
The exact age when values reach their peak bone mass in
various skeletal sites is not defined yet for sure, but the
available estimate range from 16-18 years (spine and femoral
neck), up to 35 years (the skull) (6-9).
A widely accepted element, however, is that the higher the peak
bone mass achieved in young adult age, the more an individual
can “afford” to lose bone mass in old age without getting a
fracture. A low peak bone mass will lead to a higher risk of
osteoporosis; on the contrary, a high peak bone mass will
provide a larger reserve for old age, reducing or delaying a
person’s risk of becoming osteoporotic. Therefore, the
acquisition of an optimal bone mass is an essential factor in
determining the future risk of osteoporosis and fractures (Figure
4) (1, 3, 5).
Figure 3 - Growth of bone mass
in relation to height growth veloc-
ity and difference in peak bone
mass between males (♂) and fe-
males (♀).
Figure 4 - Factors that influence
the peak bone mass and the risk
of osteopenia/osteoporosis in
adulthood.
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Markers of bone metabolism
The biochemical markers of bone turnover are very important
indicators of bone metabolism. They generally are not specific
to the process of formation or resorption, even if they can
provide information if there is a “trend “heads to a formation or
bone remodeling, providing guidance on the possible
pathogenesis of metabolic disorders and/or bone quality. All
biochemical bone turnover markers can be measured in
samples of blood and/or urine (Figure 5) (10).
In children, the biochemical markers correlate with the rate of
growth, then, they will be higher during periods of high growth, as
in the first year of life, and during the pubertal growth spurt (11).
The markers of bone formation most commonly used are:
- Serum alkaline phosphatase (ALP). The total alkaline
phosphatase in serum comprises different isoforms, as it is
an enzyme produced from many organs, including liver,
intestine and kidneys. In bone, expressed on the surface of
osteoblasts, the ALP can be cleaved from the membrane
and released into the circulation, thus the enzyme activity
can be determined in serum samples. Although the total
ALP is widely used as a marker of bone metabolism,
consisting in different isoforms measuring bone specific
isoenzyme of ALP is preferable.
- Serum osteocalcin (OC). The OC is a small protein primarily
synthesized by osteoblasts, but also by the odontoblasts
and chondrocytes. While the OC is mainly deposited in the
extracellular matrix of bone, a small amount enters the
circulation, where it is rapidly degraded. The OC has a
circadian rhythm with higher values  at night compared to
daytime.
- Carboxy-terminal Peptide of type I procollagen (PICP) in
serum. Type I collagen represents more than 90% of the
organic bone matrix. It is continuously synthesized and
degraded; from these processes, small molecular fragments
originate, indicating both the processes of bone formation
and resorption. The first, split off from the newly formed
collagen molecules are called with the term PICP or PINP
depending on the C-or N-terminal origin. PICP is eliminated
by the liver. Such as osteocalcin, it shows a circadian rhythm. 
The markers of bone resorption more frequently used are:
- Urinary Pyridinolines (PYD) and deossipyridinolines (DPD).
They are molecules released into the circulation during
bone resorption and subsequently excreted in the urine.
Although the collagen type I is present in other connective
tissues in addition to bone, the amount of PYD and DPD in
serum and urine are primarily derived from the bone which
has a greater turnover than other tissue containing
collagen. The DPD is considered more bone-specific and
therefore is a useful marker of bone resorption.
- Urinary hydroxyproline. Hydroxyproline is an aminoacid that
belongs to collagen protein. Only about 10% of the hydro-
xyproline contained in degradation products of collagen are
excreted in the urine, while most of it is reabsorbed by the
renal tubules and broken down in the liver. Another disad-
vantage is that several other sources of hydroxyproline exist,
in addition to bone resorption derived urinary hydroxyproline,
such as diet (gelatin) and breakdown of soft connective
tissue. Dietary influences can be circumvented by measuring
hydroxyproline/creatinine in the first morning void urine after
an overnight fast.
- N-telopeptides (NTX) or C-terminal (CTX) of mature
collagen type I. These markers can be measured in both
blood and urine.
- Urinary Calcium. The total daily excretion of calcium
depends on the intake of calcium. As hydroxyproline, the
influence of the diet can be minimized by measuring the
calcium/creatinine ratio  in the first urine of the morning.
- Cross-link C terminal telopeptide of collagen type I (lCTP).
ICTP is released during bone resorption of collagen. ICTP
shows a circadian rhythm, such as osteocalcin and PICP
(10, 11).
Effects of the diet on bone metabolism and structure
Calcium and vitamin D are two essential nutrients long known
for their role in bone health (12, 13).
Up to 80% of Bone Mineral Density (BMD) would be genetically
determined, while the period of the most rapid skeletal
development, which occurs in childhood and adolescence,
would account for 30-40% of the total bone mass increase (7).
Figure 5 - Biochemical markers of bone
remodelling. In the picture you can see
both the main markers of bone forma-
tion and resorption. BAP: Bone alkaline
phosphatase.
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Environmental factors such as weight-bearing exercise and
dietary intake of calcium, could affect up to 20% of BMD. About
95% of  bone accrual seems to be completed at an age of 18
years, while a further 5% is acquired up to about 30 years of
age (7-9).
Most data seem to confirm that an adequate intake of calcium
is important to reach skeletal maturity in adolescence.
Prospective randomized clinical trials have shown that calcium
supplementation may increase the acquisition of bone mass
during adolescence, early adulthood and until the third decade
of life. When that calcium supplementation ceases, the
beneficial effect on bone seems to disappear (12, 14). 
So, proper bone growth and development are related to the
amount of calcium consumed and calcium intakes recommended
to meet the needs for growth and bone development in children
and adolescents have been established by various authorities
(12). An inadequate intake of calcium may contribute to failure to
develop bone from the first months of life. Calcium intake in some
studies appeared insufficient in subgroups of children and
adolescents in some EU countries, especially in girls (12). Some
data, for example, appear to suggest that the recommended
dietary levels of calcium in order to allow a female teenager to
achieve full genetic potential of bone mass, would be superior to
1200-1500 mg/day (Table 1) (15).
Effects of exercise on metabolism and bone structure
As above mentioned, bone is a living tissue that has the ability to
respond to mechanical stimuli such as activity or exercise. The
presence of continuous stimuli by a mechanical load, therefore,
is essential to maintain a normal bone mass. Recent studies,
however, suggest that even passive mechanical stimuli could be
beneficial for the construction of a healthy bone (16-18).
The trabeculae of cancellous bone, in fact, are constantly
remodelled to fit the bones to mechanical stress. Conversely,
inactivity leads to a rapid loss of bone mass, as observed in
bedridden patients. The same happens in the case of a
reduction of the load due to, for example, a condition of absent
gravity experienced by astronauts.
The mechanical deformation produced on the bone, in fact, is
detected by osteocytes through their cell junctions, producing
a series of changes which lead to bone remodelling. For
example, sclerostin, a protein produced by osteocytes, is
thought to play a role in regulating the formation of bone,
functioning as an antagonist of the Wnt signal, namely blocking
the Wnt/b-catenin. The production of sclerostin, which is
reduced in response to mechanical loading and to the
intermittent secretion of PTH, could lead to the inhibition of
osteoblasts (i.e. of bone formation) (19).
Physical activity is a modifiable factor that can still increase bone
accretion if done regularly. In childhood and adolescence,
physical activity is still the undoubted positive effects on bone
mass, both short-term and long-term. The increase could be
higher if physical activity is initiated early and/or prepubescent.
However, what is also important in adolescence, where the bone
gain during the years of puberty, at which time physical activity
often tends to decrease is more significant physiologically. This
is especially important to maximize peak bone mass (16-18).
The importance of physical activity on bone mass has also
been confirmed in adult women in post-menopausal where, on
the basis of epidemiological studies, a long-term structured
exercise would result in a significant improvement in the
trabecular meshwork and cortical volumetric BMD (17).
Effects of vitamin D on bone growth
Surely the most important function of vitamin D, established
nearly a century ago, is to promote skeletal mineralization (20).
Vitamin D, through its action of optimizing intestinal absorption
of calcium, is essential in order to ensure the normal
calcification of the growth plate and the mineralization of
osteoid in trabecular and cortical bone (20).
Children from 1 to 5 years: 800 mg Teenagers: 1200-1500 mg 
Children from 6 to 10 years: 800-1200 mg Adults (25-50 years): 1000 mg 
Yogurth (1 cup) 140 mg Grana Padano 1200 mg 
Milk 120 mg Gruyere 1000 mg 
Caciotta, stracchino 600 mg Mozzarella (cow) 170 mg 
Gorgonzola, taleggio 600 mg Mozzarella (buffalo) 430 mg 
Caciocavallo, fontina 500 mg Dry fruits 800-1200 mg 
Ricotta (cow) 430 mg Legumes 200 mg 
Scamorza  430 mg Parsley 200 mg 
Chocolate 100 mg Lentils 100 mg 
Cauliflower 100 mg Fish 15-20 mg 
Pasta 15-20 mg Bread  15-20 mg 
 
Table 1 - Daily requirement of calcium in the different age classes (by NIH Consensus Statement, 1994) and calcium content in different foods
(per 100 ml or 100 mg) (15).
04-Stagi_-  28/01/14  17:34  Pagina 176
Clinical Cases in Mineral and Bone Metabolism 2013; 10(3): 172-179 177
Bone metabolism in children and adolescents: main characteristics of the determinants of peak bone mass
An adequate level of vitamin D is required for an effective
absorption of calcium and for the maintenance of normal blood
levels of calcium and phosphate, which in turn are required for
normal bone mineralization. The serum 25 (OH) D, or calcidiol,
is generally considered a good indicator of the nutritional status
of vitamin D (21).
The synthesis of vitamin D in the skin by the action of sunlight is
insufficient to meet the demand in European countries, especially
during the winter months when sun exposure is reduced. This is
evident also in Tuscany, where the levels of 25 (OH) D are
frequently reduced in children and adolescents in the winter
months and appear to reach levels just sufficient in many children
at the end of the summer months (22).
Therefore, an adequate intake of vitamin D during childhood and
adolescence is necessary to reach a level of vitamin D sufficient
to ensure a normal bone mineralization.
Several expert committees established the recommended
intakes of vitamin D for these categories of subjects. Some
observational studies confirm the association between serum 25
(OH) D, as an indicator of nutritional status for this vitamin, and
BMD and/or bone mineral content (BMC) in children and
adolescents, as well as the effect on BMD and BMC of the
combined integration of the usual diet with calcium and vitamin
D (23-25).
It is not, however, showed any clear indication of a specific dose-
response relationship between calcium intake or vitamin D level
and BMC or BMD, and in these studies it was not possible to
distinguish the separate effects of vitamin D and calcium (26).
A meta-analysis published in BMJ in 2011, aimed to assess the
efficacy of vitamin D supplementation in healthy children and
adolescents, included 6 clinical trials involving a total of 343
participants receiving placebo and 541 receiving vitamin D, and
showed that supplementation with vitamin D would have no
significant effect on bone mineral density measured at total hip
and forearm, but would be effective on bone density at the
lumbar-spine, although no significant differences were found
between subjects with low and high serum levels of vitamin D;
however, it has been a trend for a greater effect in patients with
lower baseline values (27). The authors, emphasizing the need
for further confirmation of these findings, conclude that dietary
supplementation with vitamin D may be relevant in boys and in
children who are deficient, especially with regard to bone density
at the lumbar-spine and the total bone mineral content (26).
So, most of the people living at latitudes above 40° north or
south, prone to develop a deficiency of vitamin D during the
respective winter months, since the main source of vitamin D is
given by exposure to sunlight, the adequacy of supply of
vitamin D during the winter depends largely on the content of
vitamin D present in foods (28-30).
Despite the availability, in many countries, of products fortified
with vitamin D, for the majority of the population, it is difficult to
maintain a sufficient level of 25 (OH) D (31). For this reason,
people who are particularly prone to develop severe vitamin D
deficiencies are the dark-skinned individuals, who generally
need more time to UV exposure to produce the same amount
of vitamin D than a white-skinned individual. Other subjects at
risk are those with obesity, nephrotic syndrome, malabsorption,
or those who take anticonvulsant or specific drugs (e.g.,
antiretroviral agents) (32).
Despite the value of 25 (OH) D is a useful parameter for
assessing individual levels of vitamin D, there is no agreement on
the fact that this measure is the best measure to assess the
actual levels; in addition, there is still considerable disagreement
about the optimal level of 25 (OH) D which should be reached
during the year (33).
It can be said, however, that 20 ng/ml or 50 nmol/l represents
a threshold value that should be achieved throughout the year
in all individuals. Supplementation with either vitamin D2
(ergocalciferol) and/or D3 (cholecalciferol) in individuals with
25 (OH) D belows that level has in fact demonstrated to
improve many clinical aspects. Values ≤ 20 ng/ml (50 nmol/l)
must therefore be considered as “vitamin D deficiency”, while
many refer to “vitamin D insufficiency” for values  between 20
(50 nmol/l) and 30 ng/ml (75 nmol/l) (34, 35).
Thus, the presence of low levels of 25 (OH) D is a serious
public health problem when you consider the lack of vitamin D
as an aspect that must be prevented or cured, since the
majority of the population falls into this category for a few
months or for most of the year. The cut-off of 20 ng/ml (50
nmol/l) still represents an important “line of demarcation”
between supporters and opponents of a vitamin D supple-
mentation or for the adoption of a program of fortification with
vitamin D (32).
With low levels of vitamin D, there is a reduced efficiency of the
intestine to absorb calcium and phosphorus, reducing in turn
the levels of ionized calcium and stimulating the secretion and
action of PTH (36). In these circumstances PTH is an important
regulator of 1-alpha-hydroxylase renal enzyme that helps to
maintain the 1, 25 (OH) 2D in the normal range to allow an
optimal intestinal calcium absorption. In addition, an increase of
PTH also leads to a stimulation of osteoclast activity and bone
turnover, which would help to maintain calcium homeostasis at
the expense of bone mineral mass, which then will be gradually
lost. Together with the phosphaturic effect linked to elevated
PTH levels, this can lead to a more or less important reduction
of bone mass and quality (36).
Especially in adults, clinical consequences of vitamin D
deficiency are also represented by the presence of isolated or
generalized pain borne by bones and muscles. Among the most
affected are the muscles of shoulder and pelvic girdles. This
weakness in adults may lead to a greater propensity to falls and
fractures (37, 38).
It is interesting to note that the consequences of a maternal diet
enriched with vitamin D may already be displayed in the uterus.
Indeed, a low maternal value of 25 (OH) D to 19 and 34 weeks
gestation was associated with a greater cross section of the
femoral metaphyseal fetus (39-45).
Regarding the effects of vitamin D levels on muscle per-
formance, studies conducted on the elderly show a strong
increase of the indices of physical performance (Amsterdam
Longitudinal Aging Study) (46). Similar results were seen in the
NHANES III. This is still interesting to see the data, especially
among children and adolescents with JIA (Juvenile Idiopathic
Arthritis), in which it is clear the action of the muscles on the
bones as a key determinant in helping to achieve or maintain a
normal bone density (47).
Another primary role of vitamin D is also to facilitate the
absorption of calcium through the action of 1,25 - (OH) 2D on
the intestine. During adolescence, and especially during
puberty, 1,25 - (OH) 2D increases the absorption of calcium, in
line with increases in bone mineral accretion. This accretive
phase could potentially increase the need for vitamin D. Studies
on the absorption of calcium in children and adolescents
between 4.9 and 16.7 years and with levels of 25 (OH) D levels
between 28 and 197 nmol/l, did not identify a relationship
between circulating levels of 25 (OH) D and the absorption of
calcium (48-50).
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Conclusions
Ensuring normal density or bone quality with a great peak bone
mass should always be a priority when dealing with children
and adolescents. For this aim, the adoption of adequate vitamin
or nutritional integration (when necessary) should be taken into
account, especially in particular categories of people.
Factors capable of altering a proper bone growth may in fact be
related to an insufficient calcium intake, reduced levels of
vitamin D, and a reduced rate of physical activity.
In any case, as the majority of bone mass is reached at the end
of the longitudinal growth of an individual, the skeleton accrual
during childhood and adolescence is an essential factor for
determining the risk of osteoporosis. Therefore, osteoporosis
should be considered as a paediatric disease with geriatric
consequences. Consequently, greater attention should be paid
to prevention strategies, since early in their developmental age.
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